American Association of Individual Investors5d
Why OS Therapies Incorporated’s (OSTX) Stock Is Down 25.00%
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OS Therapies Incorporated before investing. In this article, we go over a few key ...
Seeking Alpha19d
OS Therapies up 65% as lung osteosarcoma asset meets goal in phase 2 trial
OS Therapies (NYSE:OSTX) is up ~65% in premarket trading Wednesday after releasing phase 2b data on OST-HER2 for prevention of recurrent, fully resected, lung metastatic osteosarcoma. Results ...
Yahoo Finance4d
OS Therapies to acquire listeria programs from Ayala Pharmaceuticals
OS Therapies (OSTX) announced it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology programs and related intellectual property assets from ...
Business Wire5d
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate ...
NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it ...
Business Wire1mon
OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference
NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced ...